Surgical Ablation Market - Global Forecast to 2019

Market Overview :

The global surgical ablation market is poised to grow at a CAGR of 8.5% during 2014-2019, and is expected to reach a value of ~$1,567.0 Million in 2019. 

A number of factors such as growing geriatric population, coupled with an increasing population base of cancer and cardiovascular diseases, ongoing technological advancements in the field of ablation devices, growing awareness about benefits of ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers are fuelling the growth of the global surgical ablation market.

The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of surgical ablation products. 

Ask For Discount: https://www.marketsandmarkets.com/discountreports.asp?id=5400609

A number of factors such as success of ablation procedure in clinical trials to treat target diseases, growing adoption of ablation procedure in minimally invasive surgeries, and growing market penetration of ablation product manufacturers across developing countries are offering high growth opportunities for the players’ active in the surgical ablation market.

As of 2013, Medtronic Plc (U.S.) held the leadership position in the global surgical ablation market. Over the past three years, the company adopted new product launches, establishment of new manufacturing facilities, and strategic acquisitions as its key business strategies to ensure its dominant position in this market. 

Market Leaders: 

In addition, AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Biosense Webster Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), Galil medical, Inc. (U.S.), Olympus Corporation (Japan), Smith & Nephews Plc (U.K.), and St Jude Medical, Inc. (U.S.) are some of the other key players in this market.